OCA follow-up – Situation on March 31, 2023 Download PDF Antoine Balavoine2023-03-31T18:48:24+02:00March 31st, 2023|Other Regulated Information|
Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD Download PDF Antoine Balavoine2023-03-31T11:13:27+02:00March 31st, 2023|News, Press Releases|
OCA follow-up – Situation on March 24, 2023 Download PDF Antoine Balavoine2023-03-24T23:14:21+01:00March 24th, 2023|Other Regulated Information|
OCA follow-up – Situation on March 22, 2023 Download the PDF Antoine Balavoine2023-03-22T19:34:08+01:00March 22nd, 2023|Other Regulated Information|
OCA follow-up – Situation on March 17, 2023 Download the PDF Antoine Balavoine2023-03-17T18:47:49+01:00March 17th, 2023|Other Regulated Information|
Reduction of share capital due to losses by reduction of nominal value: number of shares unchanged Download PDF Antoine Balavoine2023-03-17T08:49:29+01:00March 17th, 2023|Other Regulated Information, Press Releases|
OCA follow-up – Situation on March 13, 2023 Download PDF Antoine Balavoine2023-03-13T21:39:38+01:00March 13th, 2023|Other Regulated Information|
Extraordinary General Meeting – 08/03/2023 Download PDF Antoine Balavoine2023-03-11T12:36:39+01:00March 10th, 2023|Shareholder's General Meeting|
OCA follow-up – Situation on March 09, 2023 Download PDF Antoine Balavoine2023-03-09T10:30:00+01:00March 9th, 2023|Other Regulated Information|
OCA follow-up – Situation on March 03, 2023 Download PDF Antoine Balavoine2023-03-03T10:22:41+01:00March 3rd, 2023|Other Regulated Information|